Comment on: British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis

Bright Uchenna Oparaji; Louis Clearkin; Scott Ferson; Marco de Angelis; Maria Ferrer-Fernandez; Dominic Calleja; Nicholas Gray; Elfrida Derrer-Merk

doi:10.1093/rheumatology/keaa265

Comment on: British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis

Bright Uchenna Oparaji, Louis Clearkin, Scott Ferson, Marco de Angelis, Maria Ferrer-Fernandez, Dominic Calleja, Nicholas Gray, Elfrida Derrer-Merk

Civil And Environmental Engineering

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Abstract

DEAR EDITOR, We thank the working party for the 2020 ‘British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis’ [1]. We feel it builds on the admirable 2010 guidance and advances GCA care.

Original language	English
Pages (from-to)	E159-E159
Number of pages	1
Journal	Rheumatology
Volume	59
Issue number	12
Early online date	23 Aug 2020
DOIs	https://doi.org/10.1093/rheumatology/keaa265
Publication status	Published - 31 Dec 2020

Keywords

rheumatology treatment
rheumatology diagnosis
clinical practice guidelines

Access to Document

10.1093/rheumatology/keaa265

Cite this

@article{6ea790cebb974ad8b6fd6092b0c24ec1,

title = "Comment on: British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis",

abstract = "DEAR EDITOR, We thank the working party for the 2020 {\textquoteleft}British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis{\textquoteright} [1]. We feel it builds on the admirable 2010 guidance and advances GCA care.",

keywords = "rheumatology treatment, rheumatology diagnosis, clinical practice guidelines",

author = "Oparaji, \{Bright Uchenna\} and Louis Clearkin and Scott Ferson and \{de Angelis\}, Marco and Maria Ferrer-Fernandez and Dominic Calleja and Nicholas Gray and Elfrida Derrer-Merk",

year = "2020",

month = dec,

day = "31",

doi = "10.1093/rheumatology/keaa265",

language = "English",

volume = "59",

pages = "E159--E159",

journal = "Rheumatology",

issn = "1462-0332",

publisher = "Oxford University Press",

number = "12",

}

TY - JOUR

T1 - Comment on: British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis

AU - Oparaji, Bright Uchenna

AU - Clearkin, Louis

AU - Ferson, Scott

AU - de Angelis, Marco

AU - Ferrer-Fernandez, Maria

AU - Calleja, Dominic

AU - Gray, Nicholas

AU - Derrer-Merk, Elfrida

PY - 2020/12/31

Y1 - 2020/12/31

N2 - DEAR EDITOR, We thank the working party for the 2020 ‘British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis’ [1]. We feel it builds on the admirable 2010 guidance and advances GCA care.

AB - DEAR EDITOR, We thank the working party for the 2020 ‘British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis’ [1]. We feel it builds on the admirable 2010 guidance and advances GCA care.

KW - rheumatology treatment

KW - rheumatology diagnosis

KW - clinical practice guidelines

U2 - 10.1093/rheumatology/keaa265

DO - 10.1093/rheumatology/keaa265

M3 - Letter

SN - 1462-0332

VL - 59

SP - E159-E159

JO - Rheumatology

JF - Rheumatology

IS - 12

ER -

Comment on: British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis

Abstract

Keywords

Access to Document

Fingerprint

Cite this